Germany-based Affimed NV has closed its previously announced offering of shares on the US Nasdaq market following the full exercise by underwriters of their option to purchase additional stock. A total of 13.8 million shares were sold at $2.50 per share raising $34.5 million. The closing was announced on 13 November.
